Vimarsana
Biggest News Aggregation in the World

Page 11 - Project Orbis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Orbis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Orbis Today - Breaking & Trending Today

Government to use Vaccine Taskforce model to tackle health challenges - Vimarsana News

Government to use Vaccine Taskforce model to tackle health challenges

Patients will benefit from cutting-edge new treatments as the government introduces a Vaccine Taskforce style approach to tackling health challenges.

Source: gov.uk
NHS England to fast-track prostate drug which can prolong survival by years - Vimarsana News

NHS England to fast-track prostate drug which can prolong survival by years

It will be the first health service in Europe to offer it after a post-Brexit partnership between UK, US and Australian medicines regulators

NICE recommends new treatment for EGFR-positive lung cancer - Vimarsana News

NICE recommends new treatment for EGFR-positive lung cancer

New therapy Mobocertinib, recommended by NICE, helps slow growth of EGFR-positive non small cell lung cancer in chemo-treated patients.

Cancer drug cooperation could save 1.5 mn lives a year: researchers - Vimarsana News

Cancer drug cooperation could save 1.5 mn lives a year: researchers

PARIS, France - Around 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs, researchers said Tuesday. The figure was based on how long it took two recent cancer drugs to be approved across the world after they were given the green light

Source: mb.com.ph
Cancer drug cooperation could save 1.5m lives a year: researchers - Vimarsana News

Cancer drug cooperation could save 1.5m lives a year: researchers

Around 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs, researchers said Tuesday.The figure was based on how long it took two recent...